Wattana Karnpaet Past Earnings Performance
Past criteria checks 2/6
Wattana Karnpaet has been growing earnings at an average annual rate of 43%, while the Healthcare industry saw earnings growing at 12.8% annually. Revenues have been growing at an average rate of 9.6% per year. Wattana Karnpaet's return on equity is 10.6%, and it has net margins of 10.2%.
Key information
43.0%
Earnings growth rate
43.0%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 9.6% |
| Return on equity | 10.6% |
| Net Margin | 10.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Wattana Karnpaet makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 492 | 50 | 62 | 0 |
| 31 Mar 24 | 491 | 54 | 58 | 0 |
| 31 Dec 23 | 482 | 56 | 59 | 0 |
| 30 Sep 23 | 484 | 61 | 43 | 0 |
| 30 Jun 23 | 495 | 73 | 45 | 0 |
| 31 Mar 23 | 504 | 83 | 58 | 0 |
| 31 Dec 22 | 523 | 100 | 63 | 0 |
| 30 Sep 22 | 511 | 92 | 87 | 0 |
| 30 Jun 22 | 444 | 58 | 84 | 0 |
| 31 Mar 22 | 390 | 36 | 69 | 0 |
| 31 Dec 21 | 333 | 9 | 62 | 0 |
| 30 Sep 21 | 305 | 4 | 56 | 0 |
| 30 Jun 21 | 305 | 4 | 57 | 0 |
| 31 Mar 21 | 291 | -3 | 61 | 0 |
| 31 Dec 20 | 313 | 2 | 67 | 0 |
| 30 Sep 20 | 327 | 6 | 69 | 0 |
| 30 Jun 20 | 350 | 13 | 74 | 0 |
| 31 Mar 20 | 379 | 17 | 80 | 0 |
| 31 Dec 19 | 375 | 17 | 80 | 0 |
| 30 Sep 19 | 371 | 10 | 82 | 0 |
| 30 Jun 19 | 368 | 9 | 81 | 0 |
| 31 Mar 19 | 373 | 18 | 79 | 0 |
| 31 Dec 18 | 366 | 17 | 79 | 0 |
| 30 Sep 18 | 353 | 29 | 62 | 0 |
| 30 Jun 18 | 346 | 33 | 61 | 0 |
| 31 Mar 18 | 327 | 27 | 58 | 0 |
| 31 Dec 17 | 309 | 18 | 56 | 0 |
| 30 Sep 17 | 311 | 12 | 71 | 0 |
| 30 Jun 17 | 299 | 6 | 71 | 0 |
| 31 Mar 17 | 297 | 5 | 70 | 0 |
| 31 Dec 16 | 304 | 11 | 69 | 0 |
| 30 Sep 16 | 314 | 12 | 71 | 0 |
| 30 Jun 16 | 321 | 15 | 67 | 0 |
| 31 Mar 16 | 327 | 14 | 66 | 0 |
| 31 Dec 15 | 325 | 13 | 65 | 0 |
| 30 Sep 15 | 313 | 9 | 59 | 0 |
| 30 Jun 15 | 301 | 6 | 59 | 0 |
| 31 Mar 15 | 291 | 9 | 57 | 0 |
| 31 Dec 14 | 290 | 11 | 55 | 0 |
| 30 Sep 14 | 279 | 6 | 55 | 0 |
| 30 Jun 14 | 280 | 8 | 53 | 0 |
| 31 Mar 14 | 280 | 13 | 49 | 0 |
| 31 Dec 13 | 269 | 11 | 46 | 0 |
Quality Earnings: NEW-R has high quality earnings.
Growing Profit Margin: NEW-R's current net profit margins (10.2%) are lower than last year (14.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEW-R's earnings have grown significantly by 43% per year over the past 5 years.
Accelerating Growth: NEW-R's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NEW-R had negative earnings growth (-31.3%) over the past year, making it difficult to compare to the Healthcare industry average (9.7%).
Return on Equity
High ROE: NEW-R's Return on Equity (10.6%) is considered low.